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Abstract
Background: Cytokines are the regulators of the immune response in tuberculosis: TNF-alpha and CXCL8 (IL-8) are involved in the granuloma formation, 
IL-10 inhibits the inflammation; some chemokines increase the liver production of the acute phase proteins (APPs). The aim of the research was to 
assess the serum level of IL-8, TNF-alpha, IL-10, C-reactive protein (CRP), ceruloplasmin and fibrinogen in patients with drug-sensitive and multidrug 
resistant tuberculosis (MDR-TB).
Material and methods: A prospective case-control study, which included 51 patients, distributed in 2 groups: the 1st study group (N=24 new cases with 
drug-sensitive TB) and the 2nd study group (N=27 new cases with MDR-TB) according to sex and age were compared with the control group (N=36 
healthy individuals).
Results: Serum concentration of IL-8 was elevated up to 13 times, TNF-alpha up to 4 times and IL-10 up to 2 times in study groups, compared with the 
reference value of the control group. Fibrinogen concentration was elevated up to 2 times in study groups compared with the control group and CRP up 
to 3 times compared with conventional value. Ceruloplasmin was statistically higher in the drug-sensitive TB and mildly elevated in MDR-TB group.
Conclusions: Proinflammatory biomarkers are more elevated than the anti-inflammatory response, without differences among groups regarding drug 
sensitiveness.
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Introduction
Evolution of tuberculosis is conditioned by the Mycobac-
teria tuberculosis (Mtb) virulence, the organism’s protective 
mechanisms and capacity to maintain the infection in latent 
state [1]. Mtb is an intracellular pathogen with a high ca-
pacity to escape from the immune host defenses. About 1,7 
billion people, 23% of the world’s population are infected 
with Mtb, but only 10% of infected individuals will develop 
active tuberculosis, more frequently pulmonary forms [2]. 
The delay between the infection and the evolution towards 
an active disease differs due to the complexity of the im-
mune suppressive risk factors [3]. In the first two years after 
the infection 5% of infected individuals will fall ill and 5% 
in a later period of life. People co-infected with HIV have a 
5-15% per year risk to fall ill with tuberculosis [4].
The most important innate immune cells involved in the 
Mtb infection are: macrophages, dendritic cells and natural 
killer cells [5, 6, 7, 8]. These immune cells express a range 
of pattern recognition receptors (PRRs) such as Toll-like 
receptors (TLRs), Nod-like receptors (NLRs) and C-type 
lectin receptors [9]. The activation of PRRs will stimulate 
the host defense functions: phagocytosis, autophagy, apop-
tosis and inflammatory cascade activation [9, 10]. Following 
the entrance in the pulmonary alveolus the Mtb infects the 
2nd type pneumocytes and polymorphonuclear neutrophils. 
After the death of the infected cells, Mtb is phagocyted by 
the alveolar macrophages, which are the first immune cells 
involved in the innate immunity and in the recruitment of 
the monocyte-derived macrophages during the early stage 
of the tuberculous infection [11]. Among the innate im-
mune cells, the macrophages play the major role in the host 
resistance against Mtb through multiple ways: production 
of the oxygen free radicals, nitric oxides, cytokines, phago-
some acidification and autophagy of the infected cells [12, 
13, 6, 14].
Before the onset of the proinflammatory cytokine cas-
cade, the innate immune cells recognize Mtb through the 
pathogen-associated molecular patterns (PAMPs). The 
PAMPs molecules are glycolipids, lipoproteins and carbo-
hydrates, which are encountered in the Mtb walls [9]. The 
recognition of the PAMPs by the PRRs of the alveolar mac-
rophages induces the production of the proinflammatory 
cytokines, more expressed IFN-gamma, IL-12, IL-1β and 
macrophage inflammatory protein-1α [15, 6, 16]. There are 
two types of macrophages involved in the innate resistance: 
classically activated macrophages (CAM) – M1 and alterna-
tively activated macrophages (AAM) – M2. The CAMs are 
induced by the interleukins secreted by the T lymphocytes 
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and have a high bactericidal activity. The alternatively ac-
tivated macrophages (AAMs) have a reduced antigen pro-
cessing capacity and are induced by the cytokines produced 
by the T helper 2 lymphocytes: IL-4, IL-13, IL-10 and TGF-β 
through the ligation with PAMPs and early secretory antigen 
6 (ESAT-6) derived from Mtb [15, 17, 6]. The role of AAMs 
is to maintain the balance between the active mycobacterial 
growth and disease evolution by suppressing the T helper 
1 lymphocytes [18]. Foam cells are the fat-laden alterna-
tively activated macrophages identified in the tuberculous 
granuloma and their formation is triggered by the uptake 
of the modified low density lipoproteins into the monocyte-
derived cells. Recently another population of macrophages 
involved in granuloma was described and defined as termed 
myeloid suppressor cells (MSCs). MSCs suppress T-cells 
responses through the secretion of the anti-inflammatory 
cytokine IL-10 and transforming growth factors [17]. Other 
innate-like cells involved in the immune defense against tu-
berculosis are: mucosal associated T cells, CD-1 restricted 
lymphocytes and natural killer T cells. It was established the 
role of the airway epithelial cells and mast cells in the early 
immune response against Mtb invasion [19]. 
The dendritic cells are important innate immune cells 
responsible for the recruitment of different cells to the site 
of infection due to their capacity to present the antigens to 
T lymphocytes from the lymph nodes, where the cell medi-
ated immune response is primarily developed. During the 
primary infection, the ligation of the dendritic cell recep-
tors by mannose-capped lipoarabinomannan of the Mtb 
reduces the production of the anti-inflammatory cytokine 
IL-10, which diminishes their maturation and decreases the 
production of other stimulator cytokines. The polymorpho-
nuclear neutrophils are also involved in the innate immu-
nity by the production of the free oxygen radicals, initiation 
of the inflammatory process and constitution of the granu-
loma, through the secretion of chemokines IL-8 and MCP-1 
[20, 16, 19, 21].
The hallmark of the Mtb infection is the granuloma 
formation. It is a histopathological structure developed 
by the host to contain the infection in the latent state and 
to eliminate the mycobacteria. Tuberculous granuloma is 
composed by a large spectrum of modified macrophages: 
multinucleated giant cells (Langhans giant cells), epitheliod 
cells and foam cells, surrounded by a crown of T lympho-
cytes. In the centre of the granuloma is placed a necrotic 
region with a characteristic caseation appearance. It was 
recognized that the cell apoptosis is bactericidal against the 
Mtb and promotes the antigen presentation, but the caseous 
necrosis releases the Mtb and contributes to progression of 
the inflammation and tissue damage [7, 8, 22]. 
The recognition of the PAMPs by the alveolar macro-
phages induces the production of the inflammatory cyto-
kines: IFN-gamma, IL-12, IL-1β and macrophage inflam-
matory protein-1α [6, 16]. The main proinflammatory 
chemokines involved in the granuloma formation are TNF-
alpha and IFN-gamma. The producers of the IFN-gamma 
are CD4+ lymphocytes (T helper 1), CD8+ lymphocytes (T 
suppressor) and natural killer cells. The role of IFN gam-
ma consists in the activation of the macrophages and the 
production of the nitric oxide. The TNF-alpha is produced 
mainly by the CD4+ lymphocytes (T helper 1) and macro-
phages [23]. The TNF-alpha role in the granuloma forma-
tion consists in the activation of macrophages and chemo-
kines production [15, 14]. The cytokine IL-10 is produced 
mainly by the B lymphocytes and AAMs [17]. The major 
role of IL-10 consists in the polarization of macrophages 
into the alternatively activated form [19]. The AAMs are in-
duced by the cytokines IL-4 and IL-13, which are produced 
by the T helper 2 lymphocytes. The AAMs produce and se-
crete the IL-10, TGF-β and arginase [18]. The chemokine 
CXCL8 (IL-8) is a proinflammatory chemokine produced 
mainly by the macrophages and infected epithelial cells of 
the respiratory tract, which have the major role in the re-
cruitment of the T lymphocytes (CD3+, CD4+ and CD8+ 
cells) and other immune cells into the infection site [18]. 
The ligation of the IL-8 to Mtb increases the ability of the 
neutrophils and macrophages to phagocyte and to kill ba-
cilli [24].
Under the influence of the chemotactic agents, such as 
IL-1, IL-6, IL-8 and TNF-alpha secreted by the innate im-
mune cells, such organs as the liver, especially the parenchi-
mal hepatocytes, increases the production and secretion of 
the acute phase proteins (APPs) [25, 26, 27]. Biochemically, 
the APPs are polypeptides. Other systems involved in the 
production of the APPs are endothelial cells, connective 
tissue and epithelial cells. The most important APPs are C-
reactive protein, haptoglobin and serum amyloid [25, 27]. 
However, several types of APPs were identified and classi-
fied into positive and negative. The positive APPs are consid-
ered a part of the innate immune system produced with the 
aim to destroy or inhibit microbes [28]. The concentration 
of the positive APPs (C-reactive protein, mannose-binding 
protein, complement factors, feritin, ceruloplasmine, serum 
amyloid A, haptoglobin and fibrinogen) increases when the 
infectious stimulus appears [25, 26, 27, 29]. Other APPs 
proteins give a negative feedback on the inflammatory re-
sponse: alpha-2-macroglobulin, serpins, coagulation factors 
[28, 26]. The coagulation factors are parts of the innate im-
mune system due to the increasing vascular permeability for 
phagocytes (neutrophil granulocytes and macrophages) and 
chemotactic agents [26]. The maximum concentration of 
APPs is revealed within 24 to 48 hours after the inflamma-
tory injury. The decline of the AAPs level is identified due to 
feedback regulations that will limit the concentration in 4-7 
days after the initial stimulus, if no further stimulus occurs. 
If the hepatic receptors are triggered continuously, the high 
level of the AAPs can become chronic. Chronic infection, 
which is revealed in the long lasting tuberculosis process 
increases the concentration of the AAPs, however the level 
is lower than in an acute infection perceived in nonspecific 
infections [25, 26, 27, 29]. Following the evaluation of the 
scientific review, we could not find data about the serum 
concentration of the cytokines and acute phase proteins in 
tuberculosis caused by Mtb with different types of resis-
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tance. The aim of the study was to assess the differences in 
the serum level of the pro-inflammatory chemokines IL-8, 
cytokine TNF-alpha, anti-inflammatory cytokine IL-10 and 
acute phase proteins: c-reactive proteins, ceruloplasmine 
and fibronogen in patients with drug susceptible and drug-
resistant tuberculosis.
Material and methods
It was realised a prospective research evaluating the 
biomarkers of the immune system in 87 cases, of which 24 
were new cases with drug susceptible pulmonary tubercu-
losis included in the 1st study group and 27 were MDR-TB 
patients which were included in the 2nd study group. The 
groups were compared between them and were compared 
with a control group (CG) composed of 36 healthy persons 
assessed according to the clinical and biochemical criteria. 
The research reported ethics committee approval (nr. 14 of 
21/11/2017) and patients’ consent was obtained. Patients 
were diagnosed in the medical specialized institutions of 
Chisinau during the period 01.01.2016-31.08.2016. Inclu- 
ding criteria in the study group were: age more than 18 years 
patients diagnosed with pulmonary tuberculosis, “new case” 
type, the diagnosis was confirmed through the conventional 
microbiological methods (microbiological examination and 
molecular genetic test of the sputum). The study investiga-
tion schedule included information about sex, age, radio-
logical aspects, microbiological patient’s status, results of 
the drug susceptibility test, treatment regimen and adverse 
drug reactions. The including criteria in the control group 
were: age more than 18 years, conventionally healthy per-
sons according to the clinical examination, blood test (com-
plete blood count) and biochemical tests (liver transami-
nases, bilirubin test, hepatitis virus serological tests, HIV 
serology). The immunological investigation of patients was 
performed during the intensive phase of the treatment. The 
36 healthy persons from the control group were investigated 
in ambulatory conditions.
The BosterBio manufecturer was chosen for the acquisi-
tion of the ELISA Kits and antibodies. The kits were pro-
vided with 96 wells per kit. For the assessment of the serum 
level of the IL-8 was used the ELISA Kits and antibodies 
for human IL-8 PicoKine. The assay results ranged from 7,8 
pg/ml till 500 pg/ml of serum or plasma. The serum level 
of the IL-10 was used in the ELISA Kit Human IL-10 Pico-
Kine with the assay range between 3,4 pg/ml till 250 pg/ml. 
The level of TNF-alpha was assessed using the kit Human 
TNF-Alpha PicoKine with the assay range between 7,8 pg/
ml till 500 pg/ml. Statistical analysis was carried out by the 
comparative assessment of the quantitative and qualitative 
peculiarities of the selected patients using the Microsoft Ex-
cel XP programme. Accumulated material was systematized 
in simple and complex groups. For the testing of significant 
differences between the studied indices of the compared 
samples it was performed the statistic non-parametric T test 
at the significant threshold p<0,05.
Results
While distributing patients, according to the biological 
characteristics was established a similar rate of men and 
women in all three groups, with the predomination of men 
in the same proportion, which was accepted as a condition 
that permitted the comparability of the results between the 
selected samples. The same proportion of young persons 
aged less than 44 years was established in all groups. All 
enumerated conditions permitted the comparability of the 
laboratory data (tab.1).
Table 1
Segregation of patients in sex and age groups
Biological 
segregation
Parameters
1st SG 
(N=24)
2nd 
SG(N=27)
CG (N=36)
N (%) N (%) N (%)
Sex stratifica-
tion
Men 14 (58%) 18 (67%) 24 (67%)
Women 10 (42%) 9 (33%) 12 (33%)
Stratification in 
age groups
18-44 years 18 (75%) 21 (77%) 29 (81%)
≥45 years 6 (25%) 5 (23%) 7 (19%)
Detected by passive way, using standard tools (microbi-
ological examination and chest X-ray) for the investigation 
of the symptomatic patients, were 15 (62%) cases from the 
1st SG and 17 (63%) cases of the 2nd SG. The main propor-
tion of both study groups was constituted from the patients 
with pulmonary infiltrative TB: 22 (91%) in the 1st SG and 
24 (89%) cases in the 2nd SG. Radiological investigations 
identified the lung destruction in all selected TB patients. 
Microbiological status was positive in all patients and drug 
susceptibility testing permitted their distribution according 
to the obtained drug resistance results. Standard treatment 
for drug-sensitive TB was administrated in patients from 
the 1st SG and standard treatment for MDR-TB in patients 
from the 2nd SG. There were no major adverse drug reactions 
identified in the selected patients. 
The assessed proinflammatory biomarkers constituted 
the serum concentration of the chemokine IL-8 and the 
cytokine TNF-alpha. The ELISA assay established that the 
concentration of IL-8 was up to 13 times more elevated in 
the groups diagnosed with tuberculosis. The concentration 
was higher even in the MDR-TB patients where the statisti-
cal threshold was not achieved. The concentrartion of the 
cytokine TNF-alpha was up to 4 times more elevated in the 
MDR-TB group and two times more elevated in the drug-
sensitive TB group compared with the healthy individuals 
included in the control group and achieved a high statistical 
threshold in both study groups compared with the control 
group. Additionally, it was established a more elevated con-
centration in the MDR-TB group compared with the drug-
sensitive TB group, achieving a high statistical threshold 
(tab. 2).
The assessed anti-inflammatory biomarker constituted 
the serum concentration of the cytokine IL-10. The concen-
tration was statistically more elevated in both study groups 
of patients with tuberculosis compared with the control 
group (tab. 3).
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Table 2
The serum level of the proinflammatory cytokines in the 
patients with drug-sensitive TB and MDR-TB
Cytokines Parameters 
1st SG (N=24) 2nd SG(N=27) CG (N=36)
M±SD M±SD M±SD
IL-8 Assay range
pg/ml serum
15.54±9.37
○
16.05±7,68
◊
1.68±1.16
Compared to 
the control 
group
1339
1383
100
TNF-alpha Assay range
pg/ml serum
141.03±66.15
●○
278.93±247.91
◊
65.77±12.09
Compared to 
the control 
group
216 427 100
Note: Values are mean ± SD. The percentage was assessed comparing the study 
groups with the reference value of the control group (100%).  Comparison 
between study groups – ● p<0.001, comparison between the 1st SG and CG – 
○ p<0.001, comparison between the 2nd SG and CG – ◊ <0.001.
Table 3
The serum level of the anti-inflammatory cytokine IL-10 
in the patients with drug-sensitive TB and MDR-TB
Cytokines Parameters 
1st SG 
(N=24)
2nd 
SG(N=27)
CG (N=36)
M±SD M±SD M±SD
IL-10 Assay range
pg/ml serum
0.08±0.04
□
0.08±0.02
■
0.06±0.011
Compared to the 
control group
133 133 100
Note: Values are mean ± SD.  The percentage was assessed comparing the 
study groups with the reference value of the control group (100%). Com- 
parison between the 1st SG and CG – □ p<0.05, comparision between the 2nd 
SG and CG – ■< 0.05.
The serum concentration of some acute phase proteins 
in tuberculosis patients established a statistically higher 
concentration of the ceruloplasmin in the drug-sensitive 
TB group and mildly elevated concentration in the MDR-
TB group. It can be explained by a longer evolution of the 
MDR-TB which contributed to an intensive negative feed-
back, which diminished the hepatic synthesis of the ceru-
loplasmin. The serum level of fibrinogen was statistically 
more elevated in both groups with tuberculosis compared 
with the reference value of the control group, without dif-
ference among groups. The concentration of the C-reactive 
protein was detectable in a three times more elevated con-
centration than the normal conventional threshold (less 
than 6 mg/dL). The investigation was not performed in the 
control group, due to the conventional negative results in 
the healthy individuals (tab. 4).
Discussion
While distributing the patients, according to the sex and 
age, it was determined the predomination of men at eco-
nomic, reproductive age (18-44 years) in both study groups, 
as well as in the control group, which was accepted as a con-
dition for the comparability of the results.  Detected, using 
standard microbiological examination and chest X-ray in-
vestigation, were two thirds of both study groups. Similar 
data were obtained in the national studies [30, 31]. The ma-
jority of both study groups was diagnosed with pulmonary 
infiltrative TB with lung destruction. Microbiological status 
was positive in all patients and drug susceptibility testing 
permitted their distribution according to the obtained drug 
resistance results. Standard treatment for the drug-sensitive 
TB was administrated in patients from the drug-sensitive 
TB group and standard treatment for MDR-TB in patients 
from the MDR-TB group. The regimens were used accord-
ing to the WHO recommendations [4, 32].
Our immune biochemical research established a simi-
lar high level of the chemokine IL-8 in patients with drug-
sensitive TB and MDR-TB. Other studies established high 
levels of IL-8 in tuberculosis and infections with mycobac-
teria other than tuberculosis [21]. The research of Ameixa 
C. proved the down-regulation of IL-8 secretion from Mtb 
infected monocytes by IL-10 [33]. Our clinical study estab-
Table 4
The serum level of the acute phase proteins ceruloplasmine and fibrinogen in the patients  
with drug-sensitive TB and MDR-TB
Cytokines Parameters 
1st SG (N=24) 2nd SG(N=27) CG (N=36)
M±SD M±SD M±SD
Ceruloplasmine Assay range mg/ml serum 911.31±210.71
□
852.11±256.1 724.3±27.8
Compared to the control group  125 117 100
Fibrinogen Assay range ng/ml serum 4.00±1.11
●
4.12±0.87
●
2.24±0.48
Compared to the control group 178 183 100
C-reactive protein mg/dL 21.87±19.57 18.57±16.99 NA
Note: Values are mean ± SD.  The percentage was assessed comparing the study groups with the reference value of the control group (100%).  
Comparison between study groups and the control group – □ p<0.001, comparison between the 1st SG and CG – ● p<0.05.  NA – non available.
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lished thirteen times higher concentration of the IL-8 com-
pared with IL-10, without differences between the study 
groups and it was not proved the regulation of Il-8 on the 
IL-10 concentration.
The concentration of the cytokine TNF-alpha was 4 
times higher in the MDR-TB group and two times higher 
in the drug-sensitive TB group compared with the healthy 
group. Elevated concentration of the cytokine TNF-alpha 
was identified in multiple studies, which proved the boosted 
capacity of the macrophages to phagocytose and kill Mtb, 
when level of TNF-alpha is increased [15, 14]. However, 
similar researches identifying the differences between the 
concentration of the TNF-alpha in the drug-sensitive TB 
and MDR-TB were not found. The concentration of IL-
10 was two times higher in both groups of patients at an 
analogical threshold. However, the concentration of IL-10 
was not elevated at a similar height as IL-8 and TNF-alpha. 
Some studies established that an increased IL-10 level con-
tributes to the survival of the Mtb in the infected host [33, 
15, 17, 34].
The serum concentration of the positive acute phase 
proteins in selected patients established a statistically higher 
concentration of the ceruloplasmine in the drug-sensitive TB 
and a non-statistically higher concentration in the MDR-TB 
group. While identifying high concetration of active phase 
reactants, fibrinogen and ceruloplasmine Cernat R.I. estab-
lished a straight correlation between those two active phase 
reactants. His research established high concentration of the 
Cu, Fe and Zn and the Cu-binding protein – ceruloplasmin 
before the initiation of the treatment [35]. However, similar 
studies to show the differences among drug susceptible and 
MDR-TB patients were not performed. Because an impor-
tant protein is involved in the protection against oxidative 
stress, ceruloplasmin could be appreciated more as antioxi-
dant than as proinflammatory biomarker [36, 37, 29]. Fi-
brinogen was found in an increased concentration in both 
groups and was established as a biomarker of tuberculous 
process by multiple researchers [38]. C-reactive protein 
was elevated in both groups of patients without differences 
among them and was interconnected with the increased 
concentration of fibrinogen and ceruloplasmin [27].
Conclusions
1.  The proinflammatory chemokine IL-8 assessed in the 
serum through the ELISA assay established that the con-
centration of the IL-8 was 13 times higher in patients with 
both types of tuberculosis, without differences among drug-
sensitive TB or MDR-TB.
2. The proinflammatory cytokine TNF-alpha was two 
times higher in the drug-sensitive TB and four times higher 
in the MDR-TB, being obtained at a high statistical thresh-
old between groups. It can be connected with the extensive-
ness of the destructive process.
3.  The anti-inflammatory cytokine IL-10 was two times 
higher in both groups of patients compared with the healthy 
individuals without any differences among groups.
4.  The serum concentration of acute phase proteins: fi-
brinogen and C-reactive protein was revealed in a statisti-
cally higher concentration in both groups of patients, com-
pared with the healthy individuals, without any differences 
among groups.
5.  Ceruloplasmine serum level was higher in the drug-
sensitive TB and non-statistically higher concentration in 
the MDR-TB group. 
6.  The proinflammatory cascade is more activated, than 
the anti-inflammatory response, without differences be-
tween drug susceptible and MDR-TB. CXCL8 (IL-8) and 
TNF-alpha can be assessed as proinflammatory biomarkers 
of tuberculosis, with no regard to the drug susceptibility. 
The serum levels of the anti-inflammatory cytokine IL-10 
and acute phase proteins are mildly increased, without dif-
ferences between the drug-sensitive and MDR-TB.
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